QUOTE AND NEWS
Business Wire  Nov 23  Comment 
NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced today that Dr. Eugene Seymour, MD MPH, CEO of the Company, presented lifetime data from the recent FluCide™ animal study on November 19th at the Influenza Congress USA 2009 in
All Allan  Nov 21  Comment 
What a long, strange trip it's been.                                               - Albert Einstein Looking back 90 days from now, remember these three charts (and, "No," I do not know or understand...
All Allan  Nov 20  Comment 
Every so often I promote a comment to its own Blog, as is the case today. Back from the Influenza conference (Dr. Seymour kindly arranged for me to attend the session). This was short (only 10 mins. per presenter) but great new results...
All Allan  Nov 18  Comment 
Wednesday and Thursday hold the potential to be news days for NNVC, as both Dr. Diwan (President) and Dr. Seymour (CEO) will be featured speakers at separate conferences.  There is always a chance that something one or both of them have to say...
All Allan  Oct 26  Comment 
NanoViricides Management Reports that the Company is Fiscally Sound and Its Drug Development Programs are Progressing Successfully Press Release Source: NanoViricides, Inc. On 7:00 am EDT, Monday October 26, 2009 WEST HAVEN, Conn.--(BUSINESS...
Business Wire  Oct 26  Comment 
NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), reports that the Company is well financed and its game changing anti-viral drug development programs are progressing successfully. As such, Management knows of no reason for the recent decline in
All Allan  Oct 25  Comment 
There have been a lot of requests for NNVC charts, so the lesson of this Blog is be careful what you ask for. I don't trade NNVC ( I am a buy & holder, period ) , but if I did, this 240 minute chart has a nice combination of sizable...
All Allan  Oct 9  Comment 
Here is a Monthly chart of NNVC . I started buying this stock way on the left side of the time line, in August, 2005, at or below 10c a share. I sold some as it started coming down off of its March, 2006 peak, but as you all know, am holding...
Business Wire  Oct 5  Comment 
NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced today that it has completed a number of financing activities. The Company has successfully raised more than $4.3M. This raise involved issuance of restricted shares and warrant
Business Wire  Sep 21  Comment 
NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), reported today that it has signed a “Master Service Agreement” with the Southern Research Institute (“Southern Research”), Birmingham, AL. Southern Research is a well established,
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 


 
NNVC AT A GLANCE
 
 
 
 
 
 
 
 

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki